MYX 0.22% $4.52 mayne pharma group limited

CEO Scott Richards - has to go, page-18

  1. 10,970 Posts.
    lightbulb Created with Sketch. 1352
    MYX will be leverage free 2022 definitely can take on additional debt 2021 on two conditions.

    1. EBITDA has increased to at least $180M by FY21
    2. Leverage is under 2.5x

    Forecasted FY20 leverage is 1.8x & FY21 1.3x

    It can, will and should take out debt 2022 if EBITDA is $200M then $500M max is more than fine providing it adds to EBITDA immediately.

    Doesnt have to be in the generics business can be in manufacturing and contracting.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.